title: An editorial for the HIV infected: immune regulation. The implications for treatment of HIV infection and the potential role of T cell suppressor pathways instead of apopstasis, anergy or direct CD4 T cell deletion in AIDS pathogenesis.
abstract: The AIDS crises makes for an interesting study of the interactions of activists, researchers, caregivers, the press, politicians and other groups in society. In the popular press and elsewhere there has been a growing movement since the inception of the disease to place efforts against AIDS as the highest standard of our benevolence, proficiency and determination when confronting a disease. Because of the potential benefit in understanding the interactions of groups and how research progressed and failed during the AIDS crises, differing perspectives should be recorded on this matter. The person currently in most need of an objective viewpoint on AIDS research, including an outlook on the past, as well as the present and future, is the person who is infected with HIV. While many of the AIDS related bureaucracies, scientists and celebrities have achieved consecration in the fight against HIV, a question arises whether this praise is deserved and really due to their keeping the AIDS patient as the first matter of the heart and mind; or whether they have merely achieved what bureaucracies and celebrity are best at, making society and those they should serve, think that they cannot do with out them.The following editorial chronicles a scandalous intellectual failure of immunologists in the fight against HIV. It delineates potential areas of concern for the HIV infected patient in the present and future, which may be important directions in the fight against HIV, both for treatment to evolve to the ideal and for an economically viable treatment for the Third World.
authors.affiliation: wthad@hotmail.com
authors.forename: T D
authors.initials: TD
authors.lastname: Wendel
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002986:Clinical Trials as Topic; D003906:Developing Countries; D032984:Ethics, Research; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D008962:Models, Theoretical; D011639:Public Opinion; D012106:Research / Q000331:legislation & jurisprudence / Q000639:trends*; D012109:Research Support as Topic; D013601:T-Lymphocytes / Q000276:immunology*